<DOC>
	<DOC>NCT00496171</DOC>
	<brief_summary>The purpose of the study is to determine the most effective formulation of HAL for release of hexaminolevulinate to the cervical epithelium at different doses.</brief_summary>
	<brief_title>Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy, premenopausal female volunteers Acute or chronic disease which could influence the study results</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>